$NROM
NOBLE ROMANS INC Stock $nrom

$nrom Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000165495423010341 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$3.739M	$3.992M	$3.750M
YoY Change	-4.33%	6.47%	4.61%
Cost Of Revenue	$2.610M	$2.666M	$2.816M
YoY Change	-9.87%	-5.31%	11.01%
Gross Profit	$1.130M	$1.326M	$934.0K
YoY Change	11.57%	41.99%	-10.88%
Gross Profit Margin	30.22%	33.22%	24.91%
Selling, General & Admin	$520.0K	$526.3K	$539.7K
YoY Change	0.3%	-2.49%	12.01%
% of Gross Profit	46.02%	39.69%	57.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$210.0K	$224.3K	$236.8K
YoY Change	-10.8%	-5.27%	-9.56%
% of Gross Profit	18.58%	16.91%	25.35%
Operating Expenses	$2.611M	$2.666M	$2.816M
YoY Change	-9.85%	-5.31%	11.01%
Operating Profit	$513.9K	$704.4K	$281.6K
YoY Change	34.59%	150.14%	-33.59%
Interest Expense	$359.4K	$378.8K	$347.7K
YoY Change	-4.91%	8.93%	2.62%
% of Operating Profit	69.94%	53.78%	123.49%
Other Income/Expense, Net
YoY Change
Pretax Income	$154.5K	$325.6K	-$66.13K
YoY Change	3911.32%	-592.3%	-177.65%
Income Tax	$0.00	$0.00	-$15.87K
% Of Pretax Income	0.0%	0.0%
Net Earnings	$154.5K	$325.6K	-$50.26K
YoY Change	3911.32%	-747.77%	-159.02%
Net Earnings / Revenue	4.13%	8.15%	-1.34%
Basic Earnings Per Share	$0.01	$0.02	$0.00
Diluted Earnings Per Share	$0.01	$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	22.22M shares	22.22M shares	22.22M shares
Diluted Shares Outstanding	23.58M shares	23.50M shares	23.58M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$560.0K	$686.0K	$900.3K
YoY Change	-24.63%	-23.8%	-55.36%
Cash & Equivalents	$563.6K	$686.0K	$900.3K
Short-Term Investments
Other Short-Term Assets	$690.0K	$410.7K	$450.6K
YoY Change	46.29%	-8.85%	-3.32%
Inventory	$942.8K	$1.005M	$994.6K
Prepaid Expenses	$691.3K	$410.7K	$450.6K
Receivables	$395.9K	$389.6K	$1.032M
Other Receivables	$510.0K	$1.460M	$0.00
Total Short-Term Assets	$3.515M	$4.368M	$3.378M
YoY Change	7.91%	29.32%	-23.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.456M	$4.552M	$5.104M
YoY Change	-11.05%	-10.82%	18.59%
Goodwill	$278.5K	$278.5K	$278.5K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.220M	$4.044M	$398.5K
YoY Change	936.56%	914.75%	70.53%
Total Long-Term Assets	$14.48M	$14.57M	$15.94M
YoY Change	-7.8%	-8.62%	9.47%
TOTAL ASSETS
Total Short-Term Assets	$3.515M	$4.368M	$3.378M
Total Long-Term Assets	$14.48M	$14.57M	$15.94M
Total Assets	$17.99M	$18.94M	$19.32M
YoY Change	-5.1%	-1.98%	1.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$190.0K	$572.1K	$739.9K
YoY Change	-52.9%	-22.68%	38.63%
Accrued Expenses	$800.0K	$799.2K	$685.3K
YoY Change	14.2%	16.61%	69.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.000M	$1.000M	$166.7K
YoY Change	275.01%	499.99%
Total Short-Term Liabilities	$1.992M	$2.371M	$1.592M
YoY Change	45.31%	48.96%	69.85%
LONG-TERM LIABILITIES
Long-Term Debt	$7.040M	$7.766M	$8.560M
YoY Change	-17.91%	-9.28%	3.54%
Other Long-Term Liabilities	$5.730M	$5.727M	$6.445M
YoY Change	-8.73%	-11.14%	-0.44%
Total Long-Term Liabilities	$12.77M	$13.49M	$15.00M
YoY Change	-14.05%	-10.08%	1.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.992M	$2.371M	$1.592M
Total Long-Term Liabilities	$12.77M	$13.49M	$15.00M
Total Liabilities	$14.76M	$15.86M	$16.60M
YoY Change	-9.03%	-4.41%	5.86%
SHAREHOLDERS EQUITY
Retained Earnings	-$21.60M	-$21.76M	-$22.08M
YoY Change	-2.15%	-1.47%	2.75%
Common Stock	$24.84M	$24.83M	$24.81M
YoY Change	0.1%	0.1%	0.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.233M	$3.073M	$2.724M
YoY Change
Total Liabilities & Shareholders Equity	$17.99M	$18.94M	$19.32M
YoY Change	-5.1%	-1.98%	1.9%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$154.5K	$325.6K	-$50.26K
YoY Change	3911.32%	-747.77%	-159.02%
Depreciation, Depletion And Amortization	$210.0K	$224.3K	$236.8K
YoY Change	-10.8%	-5.27%	-9.56%
Cash From Operating Activities	$710.0K	$538.8K	$150.6K
YoY Change	-612.38%	257.64%	-18.83%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$16.09K	-$58.35K
YoY Change	-100.0%	-127.58%	40.13%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$16.09K	-$58.35K
YoY Change	-100.0%	-72.42%	40.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-830.0K	-$300.0K	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	710.0K	$538.8K	150.6K
Cash From Investing Activities	0.000	-$16.09K	-58.35K
Cash From Financing Activities	-830.0K	-$300.0K	0.000
Net Change In Cash	-120.0K	$222.7K	92.30K
YoY Change	-23.72%	141.27%	-35.88%
FREE CASH FLOW
Cash From Operating Activities	$710.0K	$538.8K	$150.6K
Capital Expenditures	$0.00	$16.09K	-$58.35K
Free Cash Flow	$710.0K	$522.7K	$209.0K
YoY Change	-692.51%	150.09%	-8.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000709005
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22215512	shares
	nrom	Dilutive Shares DilutiveShares	0	shares
CY2023Q2	nrom	Dilutive Shares DilutiveShares	0	shares
CY2022Q2	nrom	Dilutive Shares DilutiveShares	0	shares
	nrom	Dilutive Shares DilutiveShares	0	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Entity File Number EntityFileNumber	0-11104
	dei	Entity Registrant Name EntityRegistrantName	NOBLE ROMAN’S, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	IN
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-1281154
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6612 E
	dei	Entity Address Address Line2 EntityAddressAddressLine2	75th Street
	dei	Entity Address Address Line3 EntityAddressAddressLine3	Suite 450
	dei	Entity Address City Or Town EntityAddressCityOrTown	Indianapolis
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IN
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	46250
	dei	City Area Code CityAreaCode	317
	dei	Local Phone Number LocalPhoneNumber	634-3377
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	22215512	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	785522	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	685977	usd
CY2022Q4	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	0	usd
CY2023Q2	nrom	Employee Retention Tax Credit Receivable EmployeeRetentionTaxCreditReceivable	1460444	usd
CY2022Q4	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	824091	usd
CY2023Q2	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	805924	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	997868	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	1005265	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	424822	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	410710	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	3032303	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	4368320	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4351558	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	4363377	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3116030	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3127880	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	63097	usd
CY2023Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	68858	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7530685	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7560115	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2817477	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3008510	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4713208	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4551605	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3374841	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3100651	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	934036	usd
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	943109	usd
CY2022Q4	us-gaap	Goodwill Goodwill	278466	usd
CY2023Q2	us-gaap	Goodwill Goodwill	278466	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5660155	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5305701	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	350189	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	389641	usd
CY2022Q4	us-gaap	Assets Assets	18343198	usd
CY2023Q2	us-gaap	Assets Assets	18937493	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	650582	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	572081	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	799164	usd
CY2022Q4	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	866667	usd
CY2023Q2	nrom	Current Portion Of Corbel Loan Payable CurrentPortionOfCorbelLoanPayable	1000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2316413	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2371245	usd
CY2022Q4	nrom	Term Loan Payable To Corbel TermLoanPayableToCorbel	7470900	usd
CY2023Q2	nrom	Term Loan Payable To Corbel TermLoanPayableToCorbel	7190510	usd
CY2022Q4	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2023Q2	nrom	Corbel Warrant Value CorbelWarrantValue	29037	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	622864	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	575000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5103286	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4755296	usd
CY2022Q4	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	934036	usd
CY2023Q2	us-gaap	Deferred Revenue And Credits Noncurrent DeferredRevenueAndCreditsNoncurrent	943109	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14160123	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	13492952	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22215512	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	24819736	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	24832525	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22953074	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21759227	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3073298	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18343198	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18937495	usd
CY2022Q2	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	2503363	usd
CY2023Q2	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	2373652	usd
	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	4786960	usd
	nrom	Restaurant Revenue Company Owned Craft Pizza Pub RestaurantRevenueCompanyOwnedCraftPizzaPub	4463994	usd
CY2022Q2	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	177115	usd
CY2023Q2	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	236585	usd
	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	310244	usd
	nrom	Restaurant Revenue Company Owned Non Traditional RestaurantRevenueCompanyOwnedNonTraditional	459965	usd
CY2022Q2	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1064363	usd
CY2023Q2	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	1373533	usd
	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	2098608	usd
	nrom	Revenue Recognition Services Franchise RevenueRecognitionServicesFranchise	2360875	usd
CY2022Q2	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	5051	usd
CY2023Q2	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	8674	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	19267	usd
	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	15413	usd
CY2022Q2	us-gaap	Revenues Revenues	3749892	usd
CY2023Q2	us-gaap	Revenues Revenues	3992444	usd
	us-gaap	Revenues Revenues	7215079	usd
	us-gaap	Revenues Revenues	7300247	usd
CY2022Q2	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	2162889	usd
CY2023Q2	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	2025193	usd
	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	4221418	usd
	nrom	Restaurant Expenses Company Owned Craft Pizza Pub RestaurantExpensesCompanyOwnedCraftPizzaPub	3940014	usd
CY2022Q2	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	169750	usd
CY2023Q2	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	204150	usd
	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	302626	usd
	nrom	Restaurant Expenses Company Owned Non Traditional RestaurantExpensesCompanyOwnedNonTraditional	325980	usd
CY2022Q2	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	483240	usd
CY2023Q2	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	436914	usd
	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	944595	usd
	nrom	Franchising Expenses Benefit FranchisingExpensesBenefit	-432031	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2815879	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2666257	usd
	us-gaap	Operating Expenses OperatingExpenses	5468639	usd
	us-gaap	Operating Expenses OperatingExpenses	3833963	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	112687	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	95517	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	225439	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	191033	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	539742	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	526309	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1080274	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1045140	usd
CY2022Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3468308	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3288083	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	6774352	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	5070136	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	281584	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	704361	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	440727	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2230111	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	347717	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	378785	usd
	us-gaap	Interest Expense InterestExpense	689597	usd
	us-gaap	Interest Expense InterestExpense	762074	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-66133	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	325576	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-248870	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1468037	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-15872	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-61913	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	274190	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-50261	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	325576	usd
	us-gaap	Net Income Loss NetIncomeLoss	-186957	usd
	us-gaap	Net Income Loss NetIncomeLoss	1193847	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2022Q2	nrom	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	22215512	shares
CY2023Q2	nrom	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	22215512	shares
	nrom	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	22215512	shares
	nrom	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	22215512	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q2	nrom	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	23579118	shares
CY2023Q2	nrom	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	23498764	shares
	nrom	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	23579118	shares
	nrom	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	23498764	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1866662	usd
	us-gaap	Net Income Loss NetIncomeLoss	1193847	usd
	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	12789	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3073298	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	2741327	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	325576	usd
CY2023Q2	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	6395	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	3073298	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2894564	usd
	us-gaap	Net Income Loss NetIncomeLoss	-186957	usd
	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	16111	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2723718	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	2765491	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-50261	usd
CY2022Q2	nrom	Amortization Of Value Of Employee Stock Options AmortizationOfValueOfEmployeeStockOptions	8488	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2723718	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-50261	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	325576	usd
	us-gaap	Net Income Loss NetIncomeLoss	-186957	usd
	us-gaap	Net Income Loss NetIncomeLoss	1193847	usd
CY2022Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	236802	usd
CY2023Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	211530	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	471613	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	425568	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4462	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2997	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-10561	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6464	usd
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-15872	usd
CY2023Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-61913	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	274190	usd
CY2022Q2	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	0	usd
CY2023Q2	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	0	usd
	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	0	usd
	nrom	Increase Decreasein Employee Retention Tax Credit IncreaseDecreaseinEmployeeRetentionTaxCredit	-1460444	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-145920	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	45301	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-127824	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18167	usd
CY2022Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5838	usd
CY2023Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1424	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-525	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7397	usd
CY2022Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-8992	usd
CY2023Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-9341	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-35297	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	14110	usd
CY2022Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7688	usd
CY2023Q2	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-12030	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-74095	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-39452	usd
CY2022Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	132282	usd
CY2023Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26668	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	165944	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-78501	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	150651	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	538789	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	161507	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	346552	usd
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	58349	usd
CY2023Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16094	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	524731	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29430	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58349	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16094	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-524731	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29430	usd
CY2022Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023Q2	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	50000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	50000	usd
CY2022Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	0	usd
CY2023Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	250000	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	0	usd
	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	366667	usd
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-300000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-416667	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	92302	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	222695	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-363224	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-99545	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	807987	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	463283	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1263513	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	785523	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	900289	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	685978	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	900289	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	685978	usd
CY2022Q2	us-gaap	Interest Paid Net InterestPaidNet	232088	usd
CY2023Q2	us-gaap	Interest Paid Net InterestPaidNet	269167	usd
	us-gaap	Interest Paid Net InterestPaidNet	459533	usd
	us-gaap	Interest Paid Net InterestPaidNet	540327	usd
	nrom	Government Grant GovernmentGrant	1718000	usd
	nrom	Net Benefit Or Refund NetBenefitOrRefund	1460000	usd
	nrom	Expenses Deducted ExpensesDeducted	258000	usd
	us-gaap	Interest Paid InterestPaid	1160000	usd
	us-gaap	Insurance Commissions InsuranceCommissions	1540000	usd
	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	80000	usd
CY2023Q2	nrom	Number Of Franchises Licenses In Operation NumberOfFranchisesLicensesInOperation	1400000	usd
CY2022Q2	nrom	Number Of Franchises Licenses In Operation NumberOfFranchisesLicensesInOperation	1100000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	325576	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2023Q2	nrom	Shares Denominator SharesDenominator	133252	shares
CY2023Q2	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	339951	usd
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23498764	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Profit Loss ProfitLoss	1193845	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
	nrom	Shares Denominator SharesDenominator	133252	shares
	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	1223845	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23498764	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-50261	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q2	nrom	Shares Denominator SharesDenominator	113606	shares
CY2022Q2	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	-34640	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23579118	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Profit Loss ProfitLoss	-186957	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22215512	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	nrom	Shares Denominator SharesDenominator	113606	shares
	nrom	Diluted Earnings Per Share Net Loss DilutedEarningsPerShareNetLoss	-155707	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23579118	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01

Files In Submission

Name	View Source	Status
0001654954-23-010341-index-headers.html	Edgar Link	pending
0001654954-23-010341-index.html	Edgar Link	pending
0001654954-23-010341.txt	Edgar Link	pending
0001654954-23-010341-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nrom-20230630.xsd	Edgar Link	pending
nrom_10q.htm	Edgar Link	pending
nrom_ex311.htm	Edgar Link	pending
nrom_ex312.htm	Edgar Link	pending
nrom_ex321.htm	Edgar Link	pending
nrom_ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nrom-20230630_cal.xml	Edgar Link	unprocessable
nrom-20230630_def.xml	Edgar Link	unprocessable
nrom-20230630_pre.xml	Edgar Link	unprocessable
nrom_10q_htm.xml	Edgar Link	completed
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nrom-20230630_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NROM
NOBLE ROMANS INC Stock $nrom

2023 Q3 Form 10-Q Financial Statement

#000165495423010341 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM NOBLE ROMANS INC Stock $nrom

2023 Q3 Form 10-Q Financial Statement

#000165495423010341 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NROM
NOBLE ROMANS INC Stock $nrom